Neurogene NGNE
NASDAQ NGNE
$25.65 -0.90 (-3.39%)
At close: Oct 2, 2026 · 4:00 PM EDT

Neurogene (NGNE) Sales of Property, Plant and Equipment (2013 - 2014)

Updated

Neurogene (NGNE) recorded Sales of Property, Plant and Equipment of $1,000 in FY2015, down 96.2% from $26,000 in FY2014.

Analysis

Neurogene (NGNE) Sales of Property, Plant and Equipment (2013 - 2014) Analysis & Trends

  • Per Business Quant data, NGNE's Sales of Property, Plant and Equipment was $26,000 in FY2014 (-86.5%) and $192,000 in FY2013.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) PP&E (Sale) (Qtr)
1 Eli Lilly 1,076.25 Bn 1,044.84 Bn 19.71 Bn -
2 Johnson & Johnson 617.18 Bn 535.70 Bn 17.26 Bn 63.00 Mn
3 AbbVie 464.58 Bn 437.73 Bn 12.70 Bn -
4 Merck 356.04 Bn 310.47 Bn 12.21 Bn -
5 Novartis Ag 269.07 Bn 224.94 Bn 11.24 Bn 49.00 Mn
6 Astrazeneca 243.21 Bn 216.77 Bn 12.86 Bn 4.00 Mn
7 Amgen 217.88 Bn 173.28 Bn 7.24 Bn -
8 Gilead Sciences 179.62 Bn 153.74 Bn 6.22 Bn -
9 Pfizer 158.45 Bn 105.40 Bn 10.94 Bn -
10 Neurogene 578.46 Mn 578.46 Mn - -
Historic Data

Historic Data

Download Data
DateValue
Dec 31, 2014 10,000.00
Dec 31, 2013 10,382.00
Sep 30, 2013 26,455.00
Jun 30, 2013 104,353.00
Mar 31, 2013 50,810.00
API Access

Neurogene Sales of Property, Plant and Equipment API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=sales-of-property-plant-and-equipment&ticker=NGNE&period=max&api_key=YOUR_API_KEY